(Q42573382)

English

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

scientific article published on 10 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study (English)

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

author name string

Anne-Sofie Schrohl

1

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Maxime P Look

2

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Marion E Meijer-van Gelder

3

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

John A Foekens

4

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Nils Brünner

5

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

language of work or name

0 references

publication date

10 September 2009

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

9

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

322

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

copyright license

Creative Commons Attribution 2.0 Generic

10 September 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-322

0 references

HER2, TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Advances in the treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Novel functions of TIMPs in cell signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Complex roles of tissue inhibitors of metalloproteinases in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

28 May 2018

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

16 August 2018

Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

16 August 2018

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

16 August 2018

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

16 August 2018

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

16 August 2018

Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754488

16 August 2018

High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19744322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-9-322

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42573382&oldid=1961812853"